African Medicines Agency advances toward full operationalisation following AU Summit engagement
Date: 2026-02-17
By: Nana Appiah Acquaye
The
African Medicines Agency (AMA) has taken a significant step toward full
operationalisation, marking new momentum for Africa’s medicines regulatory
system during the African Union Summit.
In
January 2026, the African Union initiated the formal handover of the African
Medicines Regulatory Harmonization (AMRH) programme from the African Union
Development Agency-NEPAD to the African Medicines Agency. The transition
signals a shift from institutional framework development to functional
implementation, positioning AMA at the center of continental regulatory
coordination.
AMA’s
engagement at the Summit featured its first High-Level Presidential Breakfast,
convened to secure political commitment and accelerate progress on key
priorities. Discussions focused on advancing the ratification of the African
Medicines Agency Treaty, mobilising sustainable financing mechanisms, and
embedding regulatory harmonisation within Africa’s broader health security and
industrialisation agenda under Agenda 2063.
Stakeholders
emphasised that robust and aligned regulatory systems are critical to
strengthening pharmaceutical manufacturing across the continent, enhancing
trust in intra-African trade, and safeguarding the quality, safety, and
efficacy of medicines.
Development
partners reaffirmed their support for the Agency’s next phase, highlighting the
strategic importance of regulatory harmonisation in improving health outcomes
and fostering resilience within Africa’s healthcare and pharmaceutical
ecosystems.
The
developments underscore growing continental efforts to build an integrated
medicines regulatory environment capable of supporting innovation, industrial
growth, and patient safety across Africa.
